Ubiquitin-conjugating enzyme E2 (UBE2), participating in various skin pathologies including melanoma [53], plays a pivotal role in inflammation by promoting nuclear factor kappa B (NF-κB) activation, pro-IL-1β ubiquitination and its proteasomal degradation [54]. Here, IL1B is linked to melanoma.